Advertisement
UK markets closed

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     

  • AIM

    755.28
    +2.16 (+0.29%)
     

  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     

  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     

  • Bitcoin GBP

    50,812.26
    -677.03 (-1.31%)
     

  • CMC Crypto 200

    1,327.26
    -69.27 (-4.96%)
     

  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     

  • DOW

    38,239.66
    +153.86 (+0.40%)
     

  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     

  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,161.01
    +243.73 (+1.36%)
     

  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Aetna CEO says has begun antitrust work on Humana deal

Reuters
Mark Bertolini, President of Aetna, speaks at the Reuters Health Summit in New York, November 10, 2010. REUTERS/Brendan McDermid

NEW YORK (Reuters) - Aetna Inc (AET.N) chief executive Mark Bertolini said on Tuesday that the company had begun making regulatory filings with both federal and state authorities related to its acquisition of Humana Inc (HUM.N).

Bertolini said the company had also begun talking to state insurance commissioners and officials in Washington D.C. about the $37 billion (£23.7 billion) deal, which he said will leave "plenty of competitors" in the Medicare markets where the combined company will operate.

(Reporting by Caroline Humer; Editing by Meredith Mazzilli)